|
EQS-News: MorphoSys AG / Key word(s): Conference MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference 08.01.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Media Release Planegg/Munich, Germany, January 8, 2024 MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced that Jean-Paul Kress, M.D., Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 3:00 p.m. PST in San Francisco, California. The company’s Chief Financial Officer, Lucinda Crabtree, Ph.D., and Chief Research and Development Officer, Tim Demuth, M.D., Ph.D., will also be in attendance and available to address questions. A live webcast of the presentation can be accessed on the Investors section of MorphoSys’ website at https://www.morphosys.com/en/investors. An archived version of the webcast will be available on the company’s website following the presentation. About MorphoSys For more information, please contact: 08.01.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group AG. The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Study finds long-term cognitive and psychiatric issues persist in COVID-19 patients two to three years post-infection
A recent study investigated whether psychiatric and cognitive symptoms commence or persist beyond a year of COVID-19-related hospitalization.
August 6, 2024